Citation Impact
Citing Papers
Identification of a Tumor Suppressor Relay between the FOXP3 and the Hippo Pathways in Breast and Prostate Cancers
2011
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
2007 StandoutNobel
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
2010
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors
2021
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
2011
2014
The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
2012
Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade
2015
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Gut Microbiota Regulates K/BxN Autoimmune Arthritis through Follicular Helper T but Not Th17 Cells
2016
CD4+ Tregs and immune control
2004 StandoutNobel
Macrophage Regulation of Tumor Responses to Anticancer Therapies
2013
Expansive discovery of chemically diverse structured macrocyclic oligoamides
2024 StandoutScienceNobel
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
2016
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Cancer immunotherapy: the beginning of the end of cancer?
2016
The development and in vivo function of T helper 9 cells
2015
How chemokines organize the tumour microenvironment
2023
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Necroptosis and its role in inflammation
2015 StandoutNature
FOXP3 expression in tumor cells and implications for cancer progression
2012
Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy
2015
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Combination cancer immunotherapy and new immunomodulatory targets
2015
Combining immunotherapy and targeted therapies in cancer treatment
2012
Nucleotide signalling during inflammation
2014 StandoutNature
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
2013
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
2014
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Coordinated regulation of myeloid cells by tumours
2012 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
2016
Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus
2020
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
2013
Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
2013
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Immune parameters affecting the efficacy of chemotherapeutic regimens
2011
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment
2014
GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation
2015
Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells
2011
Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy
2015
Emerging Biological Principles of Metastasis
2017 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
EMT: 2016
2016 Standout
FOXP3 Orchestrates H4K16 Acetylation and H3K4 Trimethylation for Activation of Multiple Genes by Recruiting MOF and Causing Displacement of PLU-1
2011
Myeloid Derived Suppressor Cells Are Present at High Frequency in Neonates and Suppress In Vitro T Cell Responses
2014
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment
2014
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
FoxP3 inhibits proliferation and induces apoptosis of gastric cancer cells by activating the apoptotic signaling pathway
2012
Therapeutic vaccines for cancer: an overview of clinical trials
2014
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial
2012
Neutrophils in cancer: neutral no more
2016 Standout
The secret ally: immunostimulation by anticancer drugs
2012
The PI3K Pathway in Human Disease
2017 Standout
Myeloid derived suppressor cells in human diseases
2011
Macrophages and Therapeutic Resistance in Cancer
2015
Glucocorticoid-induced tumor necrosis factor receptor–related protein co-stimulation facilitates tumor regression by inducing IL-9–producing helper T cells
2015
History of myeloid-derived suppressor cells
2013
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
2008 StandoutNature
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma
2017
Combinatorial Strategies for the Induction of Immunogenic Cell Death
2015
Purinergic Signaling during Inflammation
2012
CXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunity
2015
Myeloid-Derived Suppressor Cells
2017
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
2015
Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers
2016
Immuno-Navigator, a batch-corrected coexpression database, reveals cell type-specific gene networks in the immune system
2016 StandoutNobel
Inhibitory role of the transcription repressor Gfi1 in the generation of thymus-derived regulatory T cells
2013
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
2012 StandoutNobel
A role for Dicer in immune regulation
2006 StandoutNobel
Therapeutic Targeting of the Tumor Microenvironment
2021
Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells
2003 StandoutNobel
Spermidine in health and disease
2018 StandoutScience
The interaction of anticancer therapies with tumor-associated macrophages
2015
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
2017 Standout
Mechanistic basis and clinical relevance of the role of transforming growth factor-β in cancer.
2015
Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
2005 StandoutNobel
Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer
2016
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes
2004 StandoutNobel
TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner
2015
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Proapoptotic Chemotherapeutic Drugs Induce Noncanonical Processing and Release of IL-1β via Caspase-8 in Dendritic Cells
2013
Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12
2014
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Fanny Chalmin being referenced
SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth
2013
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity
2010
Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy
2010
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
2012
Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
2013
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses
2022
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
2014
Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
2012
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
2018